We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFG icon
1901
National Fuel Gas
NFG
$7.84B
-4,854
Closed -$456K
NFE icon
1902
New Fortress Energy
NFE
$78.5M
-217,927
Closed -$129K
NFLX icon
1903
Netflix
NFLX
$331B
-349,805
Closed -$33.6M
NG icon
1904
NovaGold Resources
NG
$3.83B
-41,044
Closed -$369K
NGVC icon
1905
Vitamin Cottage Natural Grocers
NGVC
$637M
-45,594
Closed -$1.18M
NHI icon
1906
National Health Investors
NHI
$3.6B
-48,506
Closed -$3.92M
NHC icon
1907
National Healthcare
NHC
$3.66B
-4,365
Closed -$697K
NMIH icon
1908
NMI Holdings
NMIH
$3.4B
-92,531
Closed -$3.47M
NMRA icon
1909
Neumora Therapeutics
NMRA
$306M
-191,677
Closed -$374K
NOTV
1910
DELISTED
Inotiv
NOTV
-12,730
Closed -$3.47K
NOW icon
1911
ServiceNow
NOW
$133B
-241,457
Closed -$25.2M
NRIM icon
1912
Northrim BanCorp
NRIM
$574M
-13,082
Closed -$299K
NRIX icon
1913
Nurix Therapeutics
NRIX
$2.77B
-62,503
Closed -$969K
NTNX icon
1914
Nutanix
NTNX
$18.3B
-241,930
Closed -$9.2M
NU icon
1915
Nu Holdings
NU
$70.4B
-43,368
Closed -$623K
NVCR icon
1916
NovoCure
NVCR
$1.99B
-59,253
Closed -$646K
NWE icon
1917
NorthWestern Energy
NWE
$4.27B
-95,891
Closed -$6.32M
NWBI icon
1918
Northwest Bancshares
NWBI
$2.26B
-19,832
Closed -$252K
NWSA icon
1919
News Corp Class A
NWSA
$16.4B
-53,705
Closed -$1.34M
NXPI icon
1920
NXP Semiconductors
NXPI
$56.9B
-3,488
Closed -$687K
OBDC icon
1921
Blue Owl Capital
OBDC
$5.57B
-15,795
Closed -$175K
OCGN icon
1922
Ocugen
OCGN
$471M
-26,365
Closed -$47.7K
OIH icon
1923
CALL
VanEck Oil Services ETF
OIH
$1.95B
-400
Closed -$162K
OII icon
1924
CALL
Oceaneering
OII
$5.28B
-2,700
Closed -$95.4K
OIS icon
1925
Oil States International
OIS
$522M
-62,017
Closed -$722K

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.